We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan's ANDA Raises Sankyo's Blood Pressure

Law360 (August 2, 2006, 12:00 AM EDT) -- Mylan Pharmaceuticals Inc. must tackle a federal patent infringement suit filed by a Japanese company trying to quell Mylan’s efforts to market a generic version of anti-hypertension drug Benicar.

The lawsuit, filed in New Jersey, accuses Mylan of infringing on Daiichi Sankyo Co. Ltd.’s U.S. patent covering olmesartan medoxomil—Benicar’s active ingredient. The patent at issue is valid until 2016, according to Daiichi Sankyo.

The plaintiffs in the suit are Sankyo Company Ltd. and Daiichi Sankyo Inc.—subsidiaries of Daiichi Sankyo Co. Ltd.—based in Tokyo and New Jersey,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.